Close

BIO World Congress Announces 2017 GreenTech Investor Sessions

Jun 8 2017
BIO today announced that eleven emerging companies will make formal presentations to investors during GreenTech Investor Sessions at the 2017 BIO World Congress on Industrial Biotechnology.

Convention to Feature Modern Ag Innovation Programming

Jun 6 2017
Washington, D.C. (June 6, 2017) – Today, BIO announced programming and speakers for its Modern Ag Innovation Day, which will take place on Tuesday, June 20th at BIO’s 2017 International Convention (June 19-22 in San Diego). Programming will feature agricultural, business, and civic leaders from around the world discussing the contributions biology-based innovations have made to agriculture.

GM Crops Increase Environmental Sustainability and Farmer Incomes

Jun 5 2017
Washington, D.C. (June 5, 2017) – Over the last twenty years, biotech crops have increased agriculture’s environmental sustainability, while providing significant economic benefits, according to a newly released global impacts study.

BIO Statement on Supreme Court Ruling in Impression Products v. Lexmark International

May 30 2017
Washington, DC (May 30, 2017) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement in response to the Supreme Court’s ruling in Impression Products  v. Lexmark International.

POET Founder, Chairman and CEO Jeff Broin to Receive 2017 BIO George Washington Carver Award

May 25 2017
BIO today announced that POET Founder, Chairman and CEO Jeff Broin will receive the 10th annual George Washington Carver Award for Innovation in Industrial Biotechnology. The award will be presented on Monday July 24, 2017, during a morning plenary session of the 2017 BIO World Congress on Industrial Biotechnology. The world’s largest industrial biotechnology and partnering event will be held July 23-26, 2017 at the Palais des congrès de Montréal in Montréal, Québec, Canada.

BIO Applauds Creation of FDA Opioid Policy Steering Committee

May 24 2017
Washington, DC (May 24, 2017) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement regarding the announced creation of an Opioid Policy Steering Committee at the Food and Drug Administration (FDA):

Astellas Expands Advocacy Engagement with Focused Outreach

May 23 2017

BIO Statement on President’s Proposed 2018 Budget

May 23 2017
Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement in response to President Trump’s FY 2018 budget proposal.

Biotech Industry Continues Strong Growth in 2016; San Diego Setting Pace for State, Nation

May 17 2017
Mayor Faulconer, Industry Leaders Reveal Latest Data, Including Major Economic Benefits of June BIO 2017 Convention

BIO Joins Diverse Coalition Promoting Market-Based Solutions to Address Prescription Drug Costs, Increase Patient Access and Choice

May 17 2017

Washington, DC (May 17, 2017) – Today, the Biotechnology Innovation Organization (BIO) joins with a diverse coalition of stakeholders in endorsing a set of pro-competition,...